Literature DB >> 11204291

Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension.

G de Simone1, V Palmieri, M J Koren, G A Mensah, M J Roman, R B Devereux.   

Abstract

OBJECTIVE: To test whether inappropriate echocardiographic left ventricular (LV) mass (i.e. higher than predicted by individual body size, sex and cardiac load [delta%LVM]) is associated with an increased rate of cardiovascular events, and whether values of LV mass lower than appropriate confer protection.
DESIGN: Prospective, longitudinal.
SETTING: Institutional, hospital outpatient clinic. PATIENTS: A total of 294 hypertensive patients, 84 with inappropriate and 21 with low LV mass (lower than appropriate). MAIN OUTCOME MEASURES: Cardiovascular fatal and non-fatal events.
RESULTS: Baseline delta%LVM was higher in patients with follow-up total (n = 50) or fatal (n = 14) events than in event-free survivors (all P < 0.0001) and predicted events independently of age and systolic pressure (all P < 0.0001). Although the performance was not better than with use of more traditional definition of LV hypertrophy, delta%LVM remained a predictor even in the subgroup of 126 patients (32 total events, 13 deaths) with clear-cut LV hypertrophy (P < 0.009). Patients with low LV mass exhibited supranormal LV chamber and midwall function, slightly higher heart rate and higher cardiac index (all P< 0.01). These patients had the same rate of events as those with appropriate LV mass.
CONCLUSIONS: In hypertensive patients, increase in LV mass beyond values required to compensate cardiac workload at a given body size and sex predicts cardiovascular risk independently of age and blood pressure, in the whole population as well as in the subset of patients with LV hypertrophy. Hypertensive patients with levels of LV mass lower than needed to compensate cardiac workload exhibit hyperdynamic circulatory status and the same risk pattern as patients with higher values of LV mass, possibly due to activation of the sympathetic system.

Entities:  

Mesh:

Year:  2001        PMID: 11204291     DOI: 10.1097/00004872-200101000-00016

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  15 in total

1.  Echocardiography in hypertension: a call for standardization from the Working Group on Heart and Hypertension of the Italian Society of Hypertension.

Authors:  Cesare Cuspidi; Maria Lorenza Muiesan; Nicola De Luca; Massimo Salvetti; Enrico Agabiti-Rosei; Giuseppe Schillaci
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-08

2.  Coexisting cardiac diseases and pressure recovery phenomenon contribute to discrepancy between the echocardiographic severity of aortic stenosis and left ventricular hypertrophy.

Authors:  Ayumu Abe; Taisei Mikami; Sanae Kaga; Kanako Tsuji; Kazunori Okada; Shinobu Yokoyama; Hisao Nishino; Masahiro Nakabachi; Mutsumi Nishida; Chikara Shimizu; Hiroyuki Iwano; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  J Echocardiogr       Date:  2013-01-09

3.  Cardio-ankle vascular index and subclinical heart disease.

Authors:  Giuseppe Schillaci; Francesca Battista; Laura Settimi; Fabio Anastasio; Giacomo Pucci
Journal:  Hypertens Res       Date:  2014-09-18       Impact factor: 3.872

4.  Predicting heart failure hospitalization and mortality by quantitative echocardiography: is body surface area the indexing method of choice? The Heart and Soul Study.

Authors:  Bryan Ristow; Sadia Ali; Beeya Na; Mintu P Turakhia; Mary A Whooley; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-03-03       Impact factor: 5.251

5.  Subclinical and clinical correlates of left ventricular wall motion abnormalities in the community.

Authors:  Connie W Tsao; Philimon Gona; Carol Salton; Peter G Danias; Susan Blease; Udo Hoffmann; Caroline S Fox; Mark Albert; Daniel Levy; Christopher J O'Donnell; Warren J Manning; Susan B Yeon
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

6.  3D Echocardiography - A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease Patients.

Authors:  M Kovářová; Z Žilinská; J Páleš; Z Kužmová; A Gažová; J Smaha; M Kužma; P Jackuliak; V Štvrtinová; J Kyselovič; J Payer
Journal:  Physiol Res       Date:  2021-11-30       Impact factor: 1.881

Review 7.  Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?

Authors:  Murilo Foppa; Bruce B Duncan; Luis E P Rohde
Journal:  Cardiovasc Ultrasound       Date:  2005-06-17       Impact factor: 2.062

8.  Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism.

Authors:  Chi-Sheng Hung; Yi-Lwun Ho; Yi-Yao Chang; Vin-Cent Wu; Xue-Ming Wu; Jen-Kuang Lee; Shih-Chieh Chueh; Yen-Hung Lin; Yuan-Shian Changh; Shao-Yu Yang; Ya-Hui Hu; Ming-Jai Sui; Ming-Fong Chen; Kwan-Dun Wu
Journal:  ScientificWorldJournal       Date:  2013-12-29

9.  Association of chronic kidney disease and peripheral artery disease with inappropriate left ventricular mass.

Authors:  Ho-Ming Su; Tsung-Hsien Lin; Po-Chao Hsu; Chee-Siong Lee; Wen-Hsien Lee; Szu-Chia Chen; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease.

Authors:  Jelena P Seferovic; Milorad Tesic; Petar M Seferovic; Katarina Lalic; Aleksandra Jotic; Tor Biering-Sørensen; Vojislav Giga; Sanja Stankovic; Natasa Milic; Ljiljana Lukic; Tanja Milicic; Marija Macesic; Jelena Stanarcic Gajovic; Nebojsa M Lalic
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.